NCTY — The9 LTD
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Measured signals that fired on NCTY
| date | signal | measured base rate |
|---|---|---|
| 2026-06-12 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| JANE STREET GROUP, LLC | 79.7K | 14.5K |
| Independent Advisor Alliance | 64.2K | 11.7K |
| Vident Advisory, LLC | 62.7K | 11.4K |
| MORGAN STANLEY | 2.3K | 418 |
| UBS Group AG | 1.8K | 329 |
| RHUMBLINE ADVISERS | 832 | 152 |
| GROUP ONE TRADING LLC | 279 | 51 |
| JPMORGAN CHASE & CO | 222 | 42 |
| HRT FINANCIAL LP | 65 | 12.0K |
| BNP PARIBAS FINANCIAL MARKETS | 5 | 1 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 6-K | 2026-08-21 | 2026-08-21 | on EDGAR ↗ |
| 6-K | 2026-08-06 | 2026-08-06 | on EDGAR ↗ |
| 3 | 2026-08-03 | 2026-07-27 | on EDGAR ↗ |
| 6-K | 2026-07-27 | 2026-07-27 | on EDGAR ↗ |
| EFFECT | 2026-07-20 | — | on EDGAR ↗ |
| F-3/A | 2026-07-20 | — | on EDGAR ↗ |
| F-3/A | 2026-06-18 | — | on EDGAR ↗ |
| F-3/A | 2026-06-02 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- The9's Investee Nanyang Biologics (NYB) Advancing toward Nasdaq Listing after RFAI Cleared Vote at Shareholders Extraordinary General Meeting · 2026-08-21
- The9's Investee Nanyang Biologics (NYB) Advancing toward Nasdaq Listing after RFAI Cleared Vote at Shareholders Extraordinary General Meeting · 2026-08-21
- The9 LTD (NCTY) filed form 6-K · 2026-08-21 · SEC EDGAR
- The9 Limited to Report Second Quarter 2026 Results on August 24, 2026 · 2026-08-17
- The9 Investee Nanyang Biologics (NYB) Advancing Planned Nasdaq Listing for the US$1.5 Billion Business Combination · 2026-08-11
Ask the AI about NCTY
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →